Atlas Trials

Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

Clinical trial NCT02975570 · WITHDRAWN

Trial details

NCT number
NCT02975570
Sponsor
Boston University
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Tuberculosis Multi Drug Resistant Active
Start date
2017-08-01
Primary completion
2021-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.